Laura A. Lane
Corporate Officer/Principal bij ELI LILLY AND COMPANY
Actieve functies van Laura A. Lane
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-08-2022 | - |
Loopbaan van Laura A. Lane
Eerdere bekende functies van Laura A. Lane
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Analist | 01-03-2019 | 01-10-2021 |
| Private Equity Investor | 01-10-2021 | 01-08-2022 | |
Virion Biotherapeutics Ltd.
 Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Operationeel Directeur | 01-03-2015 | 30-06-2018 |
| Oprichter | 01-03-2015 | 30-06-2018 |
Opleiding van Laura A. Lane
| University of Cambridge | Doctorate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 4 |
| Verenigde Staten | 2 |
Operationeel
| Private Equity Analyst | 1 |
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Virion Biotherapeutics Ltd.
Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Laura A. Lane
- Ervaring
